Paola Guglielmelli
Paola Guglielmelli
Verified email at unifi.it
Title
Cited by
Cited by
Year
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
J Nangalia, CE Massie, EJ Baxter, FL Nice, G Gundem, DC Wedge, ...
New England Journal of Medicine 369 (25), 2391-2405, 2013
14402013
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research andá…
F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ...
Blood 115 (9), 1703-1708, 2010
6962010
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861-1869, 2013
5332013
Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood 110 (3), 840-846, 2007
5162007
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
A Tefferi, P Guglielmelli, DR Larson, C Finke, EA Wassie, L Pieri, ...
Blood 124 (16), 2507-2513, 2014
4082014
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
G Rotunno, C Mannarelli, P Guglielmelli, A Pacilli, A Pancrazzi, L Pieri, ...
Blood 123 (10), 1552-1555, 2014
3672014
Prospective identification of high-risk polycythemia vera patients based on JAK2 V617F allele burden
AM Vannucchi, E Antonioli, P Guglielmelli, G Longo, A Pancrazzi, ...
Leukemia 21 (9), 1952-1959, 2007
3582007
Effect of mutation order on myeloproliferative neoplasms
CA Ortmann, DG Kent, J Nangalia, Y Silber, DC Wedge, J Grinfeld, ...
New England Journal of Medicine 372 (7), 601-612, 2015
3302015
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
A Tefferi, TL Lasho, O Abdel-Wahab, P Guglielmelli, J Patel, ...
Leukemia 24 (7), 1302-1309, 2010
3062010
Clinical correlates of JAK2 V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
AM Vannucchi, E Antonioli, P Guglielmelli, A Pardanani, A Tefferi
Leukemia 22 (7), 1299-1307, 2008
3042008
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
E Antonioli, P Guglielmelli, A Pancrazzi, C Bogani, M Verrucci, V Ponziani, ...
Leukemia 19 (10), 1847-1849, 2005
3032005
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
E Rumi, D Pietra, C Pascutto, P Guglielmelli, A MartÝnez-Trillos, I Casetti, ...
Blood, The Journal of the American Society of Hematology 124 (7), 1062-1069, 2014
2932014
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Mic˛, ...
haematologica 93 (3), 372-380, 2008
2802008
Advances in understanding and management of myeloproliferative neoplasms
AM Vannucchi, P Guglielmelli, A Tefferi
CA: a cancer journal for clinicians 59 (3), 171-191, 2009
2712009
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Pancrazzi, V Guerini, ...
Blood, The Journal of the American Society of Hematology 112 (3), 844-847, 2008
2672008
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
G Barosi, G Bergamaschi, M Marchetti, AM Vannucchi, P Guglielmelli, ...
Blood, The Journal of the American Society of Hematology 110 (12), 4030-4036, 2007
2582007
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
A Tefferi, P Guglielmelli, TL Lasho, G Rotunno, C Finke, C Mannarelli, ...
Leukemia 28 (7), 1494-1500, 2014
2562014
A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
A Rambaldi, CM Dellacasa, G Finazzi, A Carobbio, ML Ferrari, ...
British journal of haematology 150 (4), 446-455, 2010
2252010
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
P Guglielmelli, TL Lasho, G Rotunno, J Score, C Mannarelli, A Pancrazzi, ...
Leukemia 28 (9), 1804-1810, 2014
2212014
Leukocytosis and risk stratification assessment in essential thrombocythemia
A Carobbio, E Antonioli, P Guglielmelli, AM Vannucchi, F Delaini, ...
Journal of Clinical Oncology 26 (16), 2732-2736, 2008
2122008
The system can't perform the operation now. Try again later.
Articles 1–20